首页> 美国卫生研究院文献>British Journal of Clinical Pharmacology >Histamine challenge and anterior nasal rhinometry: their use in the assessment of pseudoephedrine and triprolidine as nasal decongestants in subjects with hayfever.
【2h】

Histamine challenge and anterior nasal rhinometry: their use in the assessment of pseudoephedrine and triprolidine as nasal decongestants in subjects with hayfever.

机译:组胺激发和鼻前鼻部测量:它们在花粉热受试者中评估伪麻黄碱和曲普利定作为鼻充血剂的用途。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1 Nasal airway resistance (NAR) was measured by anterior rhinometry in ten volunteers with allergic rhinitis. Measurements before and after challenge with three concentrations of histamine diphosphate showed significant rises in NAR for each challenge. 2 In a double-blind, crossover study with the same patients triprolidine (2.5 mg) and pseudoephedrine (60 mg) were shown to be equally effective in reducing the rise in NAR produced by histamine challenge to one nostril; both were significantly better than placebo. 3 The rise in NAR of both nostrils after histamine challenge to one nostril was significantly reduced after pseudoephedrine compared with placebo. This suggests that pseudoephedrine is effective in preventing reflex mucosal congestion in the unchallenged nostril. 4 No increase in the pulse rate or blood pressure of the volunteers was detected after either drug.
机译:1鼻气道阻力(NAR)通过前鼻部测量法对10名过敏性鼻炎志愿者进行了测量。用三种浓度的组胺二磷酸进行攻击之前和之后的测量表明,每次攻击的NAR均显着升高。 2在同一个患者的双盲,交叉研究中,曲普利定(2.5 mg)和伪麻黄碱(60 mg)被证明在减少组胺激发一个鼻孔引起的NAR升高方面同样有效。两者均明显优于安慰剂。 3与安慰剂相比,组麻黄碱组胺攻击一个鼻孔后,两个鼻孔的NAR升高均明显降低。这表明伪麻黄碱可有效预防未受挑战的鼻孔反射性粘膜充血。 4两种药物均未检测到志愿者的脉搏率或血压升高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号